General
Showing 449–464 of 2301 results
-
Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma
€3.03 Add to cart -
Article: Congratulations! Winner of the first CSL Behring Encouragement Grant
€3.03 Add to cart -
Article: Congress Calendar
€3.03 Add to cart -
Article: Congress Calendar
€3.03 Add to cart -
Article: Congress Calendar
€3.03 Add to cart -
Article: Congress highlights 2018
€3.03 Add to cart -
Article: Congress highlights 2018
€3.03 Add to cart -
Article: Congress Highlights 2018 Special,
€3.03 Add to cart -
Article: Congress highlights ISHL12
€3.03 Add to cart -
Article: Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
€3.03 Add to cart -
Article: Considerations on the use of low molecular weight heparins in patients with cancer and chronic kidney disease
€3.03 Add to cart -
Article: Consistent superior benefit of cobimetinib/vemurafenib over vemurafenib monotherapy across mutation subtypes in BRAF-mutated advanced melanoma
€3.03 Add to cart -
Article: Coombs-negative haemolysis in hepatosplenic T-cell lymphoma
€3.03 Add to cart -
Article: Corrigendum to “Recent advances in targeted therapies for patients with acute myeloid leukemia”
€3.03 Add to cart -
Article: Corrigendum to “Updated BHS guidelines for the treatment of diffuse large B-cell lymphoma (DLBCL): Novelties anno 2024”
€3.03 Add to cart -
Article: Cost-effectiveness of anticoagulants
€3.03 Add to cart
